Legal action initiated against fraudsters, say Dr Reddy’s-RDIF
Hyderabad firm says it will not take responsibility for the consequences of unauthorised deals, fraudulent financial transactions or sub-standard products resulting from fraud in the name of Sputnik V vaccine
Hyderabad: Hyderabad-based pharmaceuticals company Dr Reddy’s has initiated legal action against unscrupulous elements committing fraud in the name of the Sputnik V vaccine in India.
The company takes no responsibility for the consequences of unauthorised deals, fraudulent financial transactions or sub-standard products resulting from such fraud, the Russian Direct Investment Fund (RDIF) and Dr Reddy’s said in a joint statement on Friday.
“Beware of unauthorised individuals offering fake deals or procurement of the Sputnik V vaccine posing as its representatives in India. If approached, alert the authorities immediately,” they said.
Amid unsubstantiated reports and claims alleging tie-ups for the Sputnik V vaccine, the companies clarified that Dr Reddy’s has not entered into any partnership or collaboration with any party to supply the Sputnik V vaccine to residential associations, nor has the company authorised any third party or intermediary to supply the vaccine on its behalf in India.
“This is to reiterate that Dr Reddy’s Laboratories is the brand custodian of the Sputnik V vaccine in India and has the sole distribution rights of the first 250 million doses (first and second dose components included) of the vaccine in India,” they stated.
Ahead of the commercial launch of the vaccine in mid-June, Dr Reddy’s continues to engage in direct talks with the Government and the private sector to explore partnerships. Dr Reddy’s has fully put in place cold storage logistics as well as track-and-trace arrangements for the vaccine. They added, these arrangements are absolutely imperative to ensure the safety and quality of the vaccine, and for pharmacovigilance.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
